Safety results showed no increase in immune-mediated adverse events (34.0% vs 38.4%) or treatment-related adverse events ...
In real-world clinical practice, managing atopic dermatitis presents many challenges, particularly when ideal treatments are ...
The AMA is dedicated to reducing physician burnout, a significant part of which is influenced by inflation and recent cuts to Medicare. In the last 20 years, payment rates have declined 33%, putting a ...
Melanie T. Turk, PhD, RN, discusses her study on nationwide challenges program suppliers face in implementing the Medicare Diabetes Prevention Program (MDPP).
Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...
TeleMAB requests nearly doubled post-Roe v Wade reversal, especially in states with abortion restrictions, highlighting increased demand for remote services. TeleMAB offers cost, privacy, and travel ...
Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...
Earlier menopause may increase dementia risk due to its impact on brain aging and cardiac function, necessitating sex-specific dementia prevention strategies. Women experiencing early menopause face a ...
Perioperative enfortumab vedotin plus pembrolizumab demonstrated significant results in a population that represents roughly half of all patients with MIBC, explained Christof Vulsteke, MD, PhD.
Balazs Halmos, MD, discussed the potential impact of subcutaneous amivantamab for patients with EGFR -mutated NSCLC. Halmos ...
Christof Vulsteke, MD, PhD, is head of Integrated Cancer Center Ghent (IKG, Belgium) and Clinical Trial Unit Oncology Ghent.
Therefore, based on their findings, they recommend a comprehensive eye exam for patients living with MG who experience vision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results